Table 3.
List of medications at admission (A) and discharge (B) with APRs.
| A. | Admission | |||||
|---|---|---|---|---|---|---|
| Class | Medication | Guideline | APRs (Pre-PC) | APRs (Post-PC) | ||
| Yes | No | Yes | No | |||
| Analgesics | Celecoxib | CPIC | 1 | 2 | 1 | 2 |
| Codeine | CPIC | 1 | 2 | 1 | 2 | |
| Meloxicam | CPIC | 1 | 1 | |||
| Cardiovascular agents | Clopidogrel | CPIC | 2 | 3 | 3 | 2 |
| Metoprolol | DPWG | 6 | 6 | 10 | 2 | |
| Warfarin | CPIC | 5 | 8 | 8 | 5 | |
| Gastrointestinal agents | Omeprazole | CPIC | 4 | 4 | ||
| Pantoprazole | CPIC | 16 | 16 | |||
| Psychotropics | Aripiprazole | DPWG | 2 | 2 | ||
| Citalopram | CPIC | 1 | 1 | 1 | ||
| Clomipramine | CPIC | 1 | 1 | |||
| Escitalopram | CPIC | 4 | 4 | |||
| Haloperidol | DPWG | 3 | 3 | |||
| Imipramine | CPIC | 1 | 1 | |||
| Paroxetine | CPIC | 2 | 2 | |||
| Risperidone | DPWG | 1 | 18 | 2 | 17 | |
| Sertraline | CPIC | 2 | 13 | 3 | 12 | |
| Venlafaxine | DPWG | 9 | 4 | 10 | 3 | |
| Zuclopenthixol | DPWG | 1 | 1 | |||
| Total ( N = 120) | 50 (42%) | 70 (58%) | 61 (51%) | 59 (49%) | ||
| B. | Discharge | |||||
| Category | Medication | Guideline | APRs (Pre-PC) | APRs (Post-PC) | ||
| Yes | No | Yes | No | |||
| Analgesics | Celecoxib | CPIC | 2 | 2 | ||
| Codeine | CPIC | 1 | 1 | |||
| Ibuprofen | CPIC | 1 | 1 | |||
| Meloxicam | CPIC | 2 | 2 | |||
| Cardiovascular agents | Clopidogrel | CPIC | 2 | 3 | 3 | 2 |
| Metoprolol | DPWG | 6 | 5 | 10 | 1 | |
| Warfarin | CPIC | 6 | 8 | 10 | 4 | |
| Gastrointestinal agents | Omeprazole | CPIC | 4 | 4 | ||
| Pantoprazole | CPIC | 15 | 15 | |||
| Psychotropics | Aripiprazole | DPWG | 4 | 4 | ||
| Clomipramine | CPIC | 1 | 1 | |||
| Escitalopram | CPIC | 1 | 3 | 4 | ||
| Haloperidol | DPWG | 1 | 1 | |||
| Paroxetine | CPIC | 2 | 2 | |||
| Risperidone | DPWG | 2 | 20 | 2 | 20 | |
| Sertraline | CPIC | 3 | 15 | 4 | 14 | |
| Venlafaxine | DPWG | 8 | 6 | 8 | 6 | |
| Zuclopenthixol | DPWG | 1 | 1 | |||
| Total ( N = 122) | 48 (39%) | 74 (61%) | 57 (47%) | 65 (53%) | ||
Medication counts are provided pre-PC and post-PC based on the presence (Yes) or absence (No) of APRs. Pre-PC: using baseline genotype results only. Post-PC: using baseline genotype results in addition to phenoconverting effects of concomitant inhibitor/inducer medications.